Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pneumococcal Infections | 2 | 2021 | 562 | 0.58 | Why? |
| England | 9 | 2021 | 5116 | 0.28 | Why? |
| Educational Personnel | 1 | 2021 | 76 | 0.22 | Why? |
| Streptococcus pneumoniae | 3 | 2021 | 827 | 0.22 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.21 | Why? |
| Schools | 5 | 2021 | 4187 | 0.20 | Why? |
| Vaccines, Combined | 1 | 2019 | 67 | 0.19 | Why? |
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2019 | 64 | 0.19 | Why? |
| Vaccines, Conjugate | 1 | 2019 | 328 | 0.16 | Why? |
| Medical Staff | 1 | 2020 | 723 | 0.13 | Why? |
| Pneumococcal Vaccines | 1 | 2019 | 571 | 0.13 | Why? |
| Health Priorities | 1 | 2020 | 959 | 0.11 | Why? |
| Child Health | 1 | 2020 | 940 | 0.10 | Why? |
| Homes for the Aged | 1 | 2020 | 1071 | 0.10 | Why? |
| Students | 3 | 2021 | 5255 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.08 | Why? |
| Bacterial Infections | 1 | 2021 | 2229 | 0.08 | Why? |
| Population Surveillance | 2 | 2021 | 4967 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| London | 2 | 2021 | 2166 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Child | 9 | 2021 | 70012 | 0.06 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Child, Preschool | 6 | 2021 | 36283 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Patient Acceptance of Health Care | 1 | 2020 | 5002 | 0.06 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.05 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.05 | Why? |
| Haemophilus influenzae | 1 | 2021 | 196 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Streptococcus agalactiae | 1 | 2021 | 194 | 0.05 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.05 | Why? |
| Neisseria meningitidis | 1 | 2021 | 229 | 0.05 | Why? |
| Interleukin-2 | 1 | 2021 | 443 | 0.05 | Why? |
| Interrupted Time Series Analysis | 1 | 2021 | 868 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Infant | 4 | 2020 | 30274 | 0.04 | Why? |
| Serogroup | 1 | 2019 | 510 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Humans | 17 | 2021 | 930598 | 0.04 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.04 | Why? |
| Ireland | 1 | 2020 | 1456 | 0.03 | Why? |
| Public Health | 4 | 2021 | 16359 | 0.03 | Why? |
| Health Services Research | 1 | 2020 | 756 | 0.03 | Why? |
| Pharynx | 1 | 2021 | 1544 | 0.03 | Why? |
| Policy | 1 | 2021 | 1372 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Public Health Practice | 1 | 2021 | 945 | 0.03 | Why? |
| Immunization Schedule | 1 | 2019 | 1305 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Parents | 1 | 2021 | 2758 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Immunization Programs | 1 | 2019 | 2006 | 0.02 | Why? |
| Male | 6 | 2021 | 367725 | 0.02 | Why? |
| Female | 6 | 2021 | 380317 | 0.02 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.02 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Primary Health Care | 1 | 2020 | 4839 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Middle Aged | 1 | 2021 | 270681 | 0.00 | Why? |
Amin-Chowdhury's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(229)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_